We hypothesized that multiple fractions of SBRT delivered over several days may be detrimental to local dendritic cells which are required for crosspresentation of tumor antigens to naïve CD8 T cells and are likely the cellular targets of anti-CD40 (38). The gene discussed is CD40; the disease is neoplasm.